Advertisement
Home 2018

Archives

Accepting a liver from an older liver donor is associated with long-term survival benefit

ACS: Accepting Liver From Older Donor Better Than Waiting

0
Candidates who accept organ from older donor have lower mortality within and beyond 90 days
Opiate-free surgery is feasible for patients undergoing elective colon resections with anastomosis

ACS: Opiate-Free Surgery Feasible for Elective Colectomy

0
Eight-three percent of 155 patients did not need post-op narcotics; shorter length of stay with no narcotics
For patients with active radiographic axial spondyloarthritis and prior inadequate response or intolerance to one or two tumor necrosis factor inhibitors

ACR: Ixekizumab Tops Placebo in Axial Spondyloarthritis

0
Significant improvements for patients with prior inadequate response, intolerance to TNFi
For individuals with knee osteoarthritis

ACR: Walking Each Day May Cut Risk for TKA Over Five Years

0
Replacing 5 minutes of non-walking time with 5 minutes of moderate-to-vigorous walking beneficial
For patients with metastatic triple-negative breast cancer

Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer

0
Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease
Dorsal root ganglion neurostimulation therapy may reduce pain and disability in patients with chronic lower extremity and back pain

ASA: Dorsal Root Ganglion Stimulation Disrupts Back Pain

0
Drop in numerical rating scale pain score, ODI for chronic lower extremity, back pain
Patients undergoing surgery assume opioids will be most effective for postoperative pain relief

ASA: Patients Assume Post-Op Opioids Are Best for Pain Relief

0
Ninety-four percent of patients who believe they will receive opioids think they will be effective
For patients undergoing cervical or lumbar spinal fusions

ASA: Review Links Opioids With Complications Post-Spine Surgery

0
Higher postoperative pain score, worse quality of life for post-op pain management with opioids
Lorcaserin reduces the risk for diabetes in obese or overweight patients with prediabetes or without diabetes and reduces hemoglobin A1c among those with diabetes

Lorcaserin Beneficial for Diabetes in Overweight, Obese

0
Lorcaserin reduces risk for diabetes for those with prediabetes, without diabetes; reduces HbA1c
For patients with type 2 diabetes and acute coronary syndrome

Lixisenatide Cuts Kidney Damage in T2DM and Coronary Syndrome

0
Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria